[Improper equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System].
Ferrari
M D
MD
Academisch Ziekenhuis, afd. Neurologie, Leiden.
Haan
J
J
Bax
W A
WA
van Coevorden
R S
RS
Timmerman
H
H
Meijler
W J
WJ
D004087:Dihydroergotamine / Q000627:therapeutic use*; D004878:Ergotamine / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007211:Indoles / Q000494:pharmacology / Q000627:therapeutic use*; D008881:Migraine Disorders / Q000188:drug therapy*; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use; D013449:Sulfonamides / Q000494:pharmacology / Q000627:therapeutic use*; D018170:Sumatriptan; D014662:Vasoconstrictor Agents / Q000627:therapeutic use
D007211:Indoles; D017366:Serotonin Receptor Agonists; D013449:Sulfonamides; D014662:Vasoconstrictor Agents; D004087:Dihydroergotamine; D018170:Sumatriptan; D004878:Ergotamine